Given these findings, we can summarize that higher levels of exosomal PD-L1 have been associated with advanced disease and a worse prognosis in melanoma, NSCLC, HNSCC, PDAC, gastric cancer, and glioblastoma. The gene discussed is CD274; the disease is melanoma.